We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
Access to genomic testing, not therapy cost, is the biggest challenge
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
